Agenus AGEN
NASDAQ AGEN
$8.23 -0.01 (-0.06%)
As of: Sep 4, 2026 · 3:15 PM EDT

Agenus (AGEN) Common Equity (2010 - 2026)

Agenus (AGEN) posted quarterly Common Equity of -$228.0 million for Q1 2026, up 29.29% year-over-year from -$176.3 million in Q1 2025, and up 17.95% quarter-over-quarter from -$277.9 million in Q4 2025.

Analysis

Agenus (AGEN) Common Equity (2010 - 2026) Analysis & Trends

Agenus' Common Equity history runs 17 years deep, the most recent figure standing at -$228.0 million for Q1 2026.

  • In Q1 2026, Common Equity rose 29.29% year-over-year to -$228.0 million; the TTM figure through Mar 2026 stood at -$228.0 million (up 29.29% YoY), while the FY2025 annual figure was -$277.9 million, up 9.32% from the prior year.
  • Common Equity for Q1 2026 stood at -$228.0 million, up from -$277.9 million in the prior quarter.
  • The five-year high for Common Equity was $27.6 million in Q1 2022, with the low at -$336.3 million in Q2 2025.
  • The 5-year median for Common Equity is -$190.3 million (2024), against an average of -$167.9 million.
  • The sharpest annual moves came in 2022 and 2023: Common Equity soared 113.97% in 2022, then sank 874.08% in 2023.
  • Agenus' Common Equity stood at -$54.9 million in 2022, then plunged by 170.27% to -$148.4 million in 2023, then plunged by 106.51% to -$306.4 million in 2024, then advanced by 9.32% to -$277.9 million in 2025, then gained by 17.95% to -$228.0 million in 2026.
  • Business Quant data shows AGEN's Common Equity at -$228.0 million in Q1 2026, -$277.9 million in Q4 2025, and -$280.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn 20.25 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 31.71 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn 8.42 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 6.76 Bn
5 Revolution Medicines 44.02 Bn 44.02 Bn - 2.61 Bn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 5.17 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn 1.35 Bn
8 Royalty Pharma 28.43 Bn 27.59 Bn - 9.79 Bn
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 757.49 Mn
10 Agenus 340.21 Mn 340.21 Mn 34.52 Mn -205.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -205.85 Mn
Mar 31, 2026 -227.98 Mn
Dec 31, 2025 -277.86 Mn
Sep 30, 2025 -280.87 Mn
Jun 30, 2025 -336.31 Mn
Mar 31, 2025 -322.40 Mn
Dec 31, 2024 -306.42 Mn
Sep 30, 2024 -271.80 Mn
Jun 30, 2024 -220.84 Mn
Mar 31, 2024 -190.32 Mn
Dec 31, 2023 -148.38 Mn
Sep 30, 2023 -115.29 Mn
Jun 30, 2023 -76.76 Mn
Mar 31, 2023 -53.11 Mn
Dec 31, 2022 -54.90 Mn
Sep 30, 2022 -11.84 Mn
Jun 30, 2022 13.64 Mn
Mar 31, 2022 27.65 Mn
Dec 31, 2021 47.91 Mn
Sep 30, 2021 35.55 Mn